BMJ  2006;332 (14 January), doi:10.1136/bmj.332.7533.0-a

HPV triage could be cost effective

Using adjunctive testing for human papillomavirus (HPV) to triage women who have borderline and mildly dyskaryotic cervical smears costs more than repeat cytology, but it saves slightly more lives and could be cost effective in the long term. Legood and colleagues (p 79) modelled screening data of more than 10 000 women aged 25-64 from three centres participating in NHS pilot studies (p 83) which found that HPV triage leads to reduced rates of repeat smears but increased referrals to colposcopy.

Credit: SPL

 

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies

Rosa Legood, Alastair Gray, Jane Wolstenholme, and Sue Moss
BMJ 2006 332: 79-85. [Abstract] [Full Text] [PDF]

Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study

Sue Moss, Alastair Gray, Rosa Legood, Martin Vessey, Julietta Patnick, Henry Kitchener Liquid Based Cytology/Human Papillomavirus Cervical Pilot Studies Group
BMJ 2006 332: 83-85. [Abstract] [Full Text] [PDF]